These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8261885)

  • 1. Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV.
    Cottler LB; Shillington AM; Compton WM; Mager D; Spitznagel EL
    Drug Alcohol Depend; 1993 Sep; 33(2):97-104. PubMed ID: 8261885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should tolerance and withdrawal be required for substance dependence disorders?
    Carroll KM; Rounsaville BJ; Bryant KJ
    Drug Alcohol Depend; 1994 Aug; 36(1):15-22. PubMed ID: 7988354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CIDI-core substance abuse and dependence questions: cross-cultural and nosological issues. The WHO/ADAMHA Field Trial.
    Cottler LB; Robins LN; Grant BF; Blaine J; Towle LH; Wittchen HU; Sartorius N
    Br J Psychiatry; 1991 Nov; 159():653-8. PubMed ID: 1756341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agreement between DSM-III and III-R substance use disorders.
    Cottler LB; Helzer JE; Mager D; Spitznagel EL; Compton WM
    Drug Alcohol Depend; 1991 Dec; 29(1):17-25. PubMed ID: 1797516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component.
    Schuckit MA; Daeppen JB; Danko GP; Tripp ML; Smith TL; Li TK; Hesselbrock VM; Bucholz KK
    Am J Psychiatry; 1999 Jan; 156(1):41-9. PubMed ID: 9892296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN.
    Compton WM; Cottler LB; Dorsey KB; Spitznagel EL; Mager DE
    Drug Alcohol Depend; 1996 Jul; 41(3):179-87. PubMed ID: 8842630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mr R: a case study of withdrawal.
    Dennison SJ
    Behav Med; 1992; 18(3):139-40. PubMed ID: 1330103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.
    Stine SM; Kosten TR
    Am J Drug Alcohol Abuse; 1994 Nov; 20(4):445-58. PubMed ID: 7832179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construct validity of the abuse-dependence distinction as measured by DSM-IV criteria for different psychoactive substances.
    Feingold A; Rounsaville B
    Drug Alcohol Depend; 1995 Aug; 39(2):99-109. PubMed ID: 8529538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DSM-IV field trial for substance use disorders: major results.
    Cottler LB; Schuckit MA; Helzer JE; Crowley T; Woody G; Nathan P; Hughes J
    Drug Alcohol Depend; 1995 Apr; 38(1):59-69; discussion 71-83. PubMed ID: 7648998
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine.
    Sofuoglu M; Dudish-Poulsen S; Brown SB; Hatsukami DK
    Drug Alcohol Depend; 2003 Apr; 69(3):273-82. PubMed ID: 12633913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic concordance of DSM-III-R, DSM-IV, and ICD-10 inhalant use disorders.
    Howard MO; Cottler LB; Compton WM; Ben-Abdallah A
    Drug Alcohol Depend; 2001 Feb; 61(3):223-8. PubMed ID: 11164686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross system agreement for substance use disorders: DSM-III-R, DSM-IV and ICD-10.
    Rounsaville BJ; Bryant K; Babor T; Kranzler H; Kadden R
    Addiction; 1993 Mar; 88(3):337-48. PubMed ID: 8461851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units].
    Chrostek Maj J; Kroch S; Kamenczak A; Polewka A; Szerszeń-Motyka J
    Przegl Lek; 2004; 61(4):317-9. PubMed ID: 15521592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of psychotic symptoms in substance users: a comparison across substances.
    Smith MJ; Thirthalli J; Abdallah AB; Murray RM; Cottler LB
    Compr Psychiatry; 2009; 50(3):245-50. PubMed ID: 19374969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the psychoactive substance dependence syndrome in its application to opiate users.
    Stripp AM; Burgess PM; Pattison PE; Pead J; Holman CP
    Br J Addict; 1990 May; 85(5):621-7. PubMed ID: 2354277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorder: abuse, dependence and dyscontrol.
    Widiger TA; Smith GT
    Addiction; 1994 Mar; 89(3):267-82. PubMed ID: 8173493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance between DSM-III-R and DSM-IV diagnoses of substance use disorders in adolescents.
    Mikulich SK; Hall SK; Whitmore EA; Crowley TJ
    Drug Alcohol Depend; 2001 Feb; 61(3):237-48. PubMed ID: 11164688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of ICD-10 and DSM-III-R criteria for substance abuse and dependence.
    Rapaport MH; Tipp JE; Schuckit MA
    Am J Drug Alcohol Abuse; 1993; 19(2):143-51. PubMed ID: 8387239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should protracted withdrawal from drugs be included in DSM-IV?
    Satel SL; Kosten TR; Schuckit MA; Fischman MW
    Am J Psychiatry; 1993 May; 150(5):695-704. PubMed ID: 8097618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.